Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization
International Journal of Molecular Sciences · 23.01.2026 · 27 (3) · 1147
DOI: 10.3390/ijms27031147 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.01.2026. Verfasst von Justyna Sopel und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biophysics and Cancer Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland. Hauptthemen laut MEDLINE: Melanogenesis, Neovascularization, Pathologic, gp100 Melanoma Antigen, Melanins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Strategic Programme Excellence Initiative at Jagiellonian University.
Abstract (Originalsprache)
Premelanosomal protein (Pmel, also known as Pmel17) is the major component of melanosomal fibrils and plays a key role in melanin polymerization, making it an important factor in melanogenesis. We investigated how the absence of Pmel affects the properties of B16F10 melanoma cells. Pmel-knockout B16F10 cells were generated using CRISPR/Cas9-mediated genome editing. A viability assay revealed no significant differences between wild-type (WT) and Pmel-knockout (KO) sublines; however, melanosome maturation was impaired. In Pmel KO cells, the cell cycle was disrupted, and higher levels of reactive oxygen species (ROS) were observed compared with WT cells. Moreover, the migration capacity and tube formation of melanoma cells were increased. Tumors derived from Pmel KO cells exhibited unchanged growth kinetics but reduced melanin content, along with enhanced vascularization and oxygenation. Thus, knockout of the Pmel17 gene in melanoma cells alters pigmentation, vascularization, and oxygenation of tumors. These parameters are crucial for both tumor progression and therapeutic response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biophysics and Cancer Biology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
- Doctoral School of Exact and Natural Sciences, Jagiellonian University, 30-348 Krakow, Poland.
- Department of Medical Biotechnology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
- Department of Biophysics, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
- Department of Dermatology, Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
- Pathology and Laboratory Medicine Service, VA Medical Center, Birmingham, AL 35294, USA.
ORCID-Profile: Justyna Sopel, Katarzyna Sarad, Anna Kozinska, Krystian Mokrzyński, Dariusz Szczygieł, Aleksandra Murzyn, Andrzej Słomiński, Małgorzata Szczygieł, Martyna Elas
Förderung
- Strategic Programme Excellence Initiative at Jagiellonian University
Zitieren
APA
Sopel, J., Sarad, K., Kozinska, A., Mokrzyński, K., Szczygieł, D., Murzyn, A., Drzał, A., Słomiński, A., Szczygieł, M., & Elas, M. (2026). Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization. International Journal of Molecular Sciences, 27(3), 1147. https://doi.org/10.3390/ijms27031147
Vancouver
Sopel J, Sarad K, Kozinska A, Mokrzyński K, Szczygieł D, Murzyn A, et al. Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization. International Journal of Molecular Sciences. 2026;27(3):1147. doi:10.3390/ijms27031147
BibTeX
@article{Sopel2026,
author = {Sopel, Justyna and Sarad, Katarzyna and Kozinska, Anna and Mokrzyński, Krystian and Szczygieł, Dariusz and Murzyn, Aleksandra and Drzał, Agnieszka and Słomiński, Andrzej and Szczygieł, Małgorzata and Elas, Martyna},
title = {Pmel17 Deficiency Affects Melanogenesis and Promotes Tumor Vascularization},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {3},
pages = {1147},
doi = {10.3390/ijms27031147}
}
EUVIMED